Literature DB >> 24176436

A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction--the China Rural Health Initiative Sodium Reduction Study.

Nicole Li1, Lijing L Yan, Wenyi Niu, Darwin Labarthe, Xiangxian Feng, Jingpu Shi, Jianxin Zhang, Ruijuan Zhang, Yuhong Zhang, Hongling Chu, Andrea Neiman, Michael Engelgau, Paul Elliott, Yangfeng Wu, Bruce Neal.   

Abstract

BACKGROUND: Cardiovascular diseases are the leading cause of death and disability in China. High blood pressure caused by excess intake of dietary sodium is widespread and an effective sodium reduction program has potential to improve cardiovascular health.
DESIGN: This study is a large-scale, cluster-randomized, trial done in five Northern Chinese provinces. Two counties have been selected from each province and 12 townships in each county making a total of 120 clusters. Within each township one village has been selected for participation with 1:1 randomization stratified by county. The sodium reduction intervention comprises community health education and a food supply strategy based upon providing access to salt substitute. Subsidization of the price of salt substitute was done in 30 intervention villages selected at random. Control villages continued usual practices. The primary outcome for the study is dietary sodium intake level estimated from assays of 24-hour urine. TRIAL STATUS: The trial recruited and randomized 120 townships in April 2011. The sodium reduction program was commenced in the 60 intervention villages between May and June of that year with outcome surveys scheduled for October to December 2012. Baseline data collection shows that randomisation achieved good balance across groups. DISCUSSION: The establishment of the China Rural Health Initiative has enabled the launch of this large-scale trial designed to identify a novel, scalable strategy for reduction of dietary sodium and control of blood pressure. If proved effective, the intervention could plausibly be implemented at low cost in large parts of China and other countries worldwide.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24176436      PMCID: PMC3919684          DOI: 10.1016/j.ahj.2013.07.009

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  Randomized trials of sodium reduction: an overview.

Authors:  J A Cutler; D Follmann; P S Allender
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

Review 2.  Reduced dietary salt for the prevention of cardiovascular disease.

Authors:  Rod S Taylor; Kate E Ashton; Tiffany Moxham; Lee Hooper; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

3.  Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men.

Authors:  Hsing-Yi Chang; Yu-Whuei Hu; Ching-Syang Jack Yue; Yu-Wen Wen; Wen-Ting Yeh; Li-San Hsu; Shin-Yin Tsai; Wen-Harn Pan
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

4.  Priority actions for the non-communicable disease crisis.

Authors:  Robert Beaglehole; Ruth Bonita; Richard Horton; Cary Adams; George Alleyne; Perviz Asaria; Vanessa Baugh; Henk Bekedam; Nils Billo; Sally Casswell; Michele Cecchini; Ruth Colagiuri; Stephen Colagiuri; Tea Collins; Shah Ebrahim; Michael Engelgau; Gauden Galea; Thomas Gaziano; Robert Geneau; Andy Haines; James Hospedales; Prabhat Jha; Ann Keeling; Stephen Leeder; Paul Lincoln; Martin McKee; Judith Mackay; Roger Magnusson; Rob Moodie; Modi Mwatsama; Sania Nishtar; Bo Norrving; David Patterson; Peter Piot; Johanna Ralston; Manju Rani; K Srinath Reddy; Franco Sassi; Nick Sheron; David Stuckler; Il Suh; Julie Torode; Cherian Varghese; Judith Watt
Journal:  Lancet       Date:  2011-04-05       Impact factor: 79.321

5.  Projected effect of dietary salt reductions on future cardiovascular disease.

Authors:  Kirsten Bibbins-Domingo; Glenn M Chertow; Pamela G Coxson; Andrew Moran; James M Lightwood; Mark J Pletcher; Lee Goldman
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

6.  Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial.

Authors: 
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

7.  Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002.

Authors:  Yangfeng Wu; Rachel Huxley; Liming Li; Vibeke Anna; Gaoqiang Xie; Chonghua Yao; Mark Woodward; Xian Li; John Chalmers; Runlin Gao; Lingzhi Kong; Xiaoguang Yang
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

8.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).

Authors:  Nancy R Cook; Jeffrey A Cutler; Eva Obarzanek; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  BMJ       Date:  2007-04-20

9.  Distribution of major health risks: findings from the Global Burden of Disease study.

Authors:  Anthony Rodgers; Majid Ezzati; Stephen Vander Hoorn; Alan D Lopez; Ruey-Bin Lin; Christopher J L Murray
Journal:  PLoS Med       Date:  2004-10-19       Impact factor: 11.069

10.  Developing and evaluating complex interventions: the new Medical Research Council guidance.

Authors:  Peter Craig; Paul Dieppe; Sally Macintyre; Susan Michie; Irwin Nazareth; Mark Petticrew
Journal:  BMJ       Date:  2008-09-29
View more
  23 in total

1.  Salt sales survey: a simplified, cost-effective method to evaluate population salt reduction programs--a cluster-randomized trial.

Authors:  Yuan Ma; Feng J He; Nicole Li; Jesse Hao; Jing Zhang; Lijing L Yan; Yangfeng Wu
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

2.  Sodium and cardiovascular disease: what the data show.

Authors:  Paul K Whelton; Lawrence J Appel
Journal:  Am J Hypertens       Date:  2014-09       Impact factor: 2.689

Review 3.  A Meta-Analysis of Effect of Dietary Salt Restriction on Blood Pressure in Chinese Adults.

Authors:  Miao Wang; Andrew E Moran; Jing Liu; Yue Qi; Wuxiang Xie; Keane Tzong; Dong Zhao
Journal:  Glob Heart       Date:  2015-02-07

Review 4.  Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.

Authors:  Amanda Brand; Marianne E Visser; Anel Schoonees; Celeste E Naude
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

Review 5.  Dietary Sodium Intake and Serum Uric Acid: A Mini-Review.

Authors:  Lei Lei; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2018-07-18

Review 6.  Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China.

Authors:  Yangfeng Wu; Emelia J Benjamin; Stephen MacMahon
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

7.  Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial.

Authors:  Hao Sun; Bing Ma; Xiaomei Wu; Hailong Wang; Bo Zhou
Journal:  Front Cardiovasc Med       Date:  2021-05-17

8.  Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial.

Authors:  Sudhir Raj Thout; Jie Yu; Maoyi Tian; Mark D Huffman; Clare Arnott; Qiang Li; Praveen Devarsetty; Claire Johnson; Simone Pettigrew; Bruce Neal; Jason H Y Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-25       Impact factor: 3.738

9.  Altered dietary salt intake for people with chronic kidney disease.

Authors:  Emma J McMahon; Katrina L Campbell; Judith D Bauer; David W Mudge; Jaimon T Kelly
Journal:  Cochrane Database Syst Rev       Date:  2021-06-24

10.  Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial.

Authors:  Lijing L Yan; Weigang Fang; Elizabeth Delong; Bruce Neal; Eric D Peterson; Yining Huang; Ningling Sun; Chen Yao; Xian Li; Stephen MacMahon; Yangfeng Wu
Journal:  BMC Public Health       Date:  2014-04-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.